BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, Shu Y. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18:157. [PMID: 31711497 DOI: 10.1186/s12943-019-1089-9] [Cited by in Crossref: 221] [Cited by in F6Publishing: 223] [Article Influence: 73.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhou ZH, Liang SY, Zhao TC, Chen XZ, Cao XK, Qi M, Huang YY, Ju WT, Yang M, Zhu DW, Pang YC, Zhong LP. Overcoming chemotherapy resistance using pH-sensitive hollow MnO2 nanoshells that target the hypoxic tumor microenvironment of metastasized oral squamous cell carcinoma. J Nanobiotechnology 2021;19:157. [PMID: 34039370 DOI: 10.1186/s12951-021-00901-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kuriyama N, Yoshioka Y, Kikuchi S, Azuma N, Ochiya T. Extracellular Vesicles Are Key Regulators of Tumor Neovasculature. Front Cell Dev Biol 2020;8:611039. [PMID: 33363175 DOI: 10.3389/fcell.2020.611039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Gao F, Wang Z, Gu J, Zhang X, Wang H. A Hypoxia-Associated Prognostic Gene Signature Risk Model and Prognosis Predictors in Gliomas. Front Oncol 2021;11:726794. [PMID: 34868920 DOI: 10.3389/fonc.2021.726794] [Reference Citation Analysis]
4 Ding S, He L, Bian X, Tian G. Metal-organic frameworks-based nanozymes for combined cancer therapy. Nano Today 2020;35:100920. [DOI: 10.1016/j.nantod.2020.100920] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
5 Gao X, Dong QZ. Advance in metabolism and target therapy in breast cancer stem cells. World J Stem Cells 2020; 12(11): 1295-1306 [PMID: 33312399 DOI: 10.4252/wjsc.v12.i11.1295] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Yu Z, Hou Y, Zhou W, Zhao Z, Liu Z, Fu A. The effect of mitochondrial transplantation therapy from different gender on inhibiting cell proliferation of malignant melanoma. Int J Biol Sci 2021;17:2021-33. [PMID: 34131403 DOI: 10.7150/ijbs.59581] [Reference Citation Analysis]
7 Haitani T, Kobayashi M, Koyasu S, Akamatsu S, Suwa T, Onodera Y, Nam JM, Nguyen PTL, Menju T, Date H, Ogawa O, Harada H. Proteolysis of a histone acetyl reader, ATAD2, induces chemoresistance of cancer cells under severe hypoxia by inhibiting cell cycle progression in S phase. Cancer Lett 2022;528:76-84. [PMID: 34973392 DOI: 10.1016/j.canlet.2021.12.028] [Reference Citation Analysis]
8 He Z, Yan H, Zeng W, Yang K, Rong P. Tumor microenvironment-responsive multifunctional nanoplatform based on MnFe2O4-PEG for enhanced magnetic resonance imaging-guided hypoxic cancer radiotherapy. J Mater Chem B 2021;9:1625-37. [PMID: 33475658 DOI: 10.1039/d0tb02631j] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ge L, Zhou F, Nie J, Wang X, Zhao Q. Hypoxic colorectal cancer-secreted exosomes deliver miR-210-3p to normoxic tumor cells to elicit a protumoral effect. Exp Biol Med (Maywood) 2021;246:1895-906. [PMID: 33969722 DOI: 10.1177/15353702211011576] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Codony VL, Tavassoli M. Hypoxia-induced therapy resistance: Available hypoxia-targeting strategies and current advances in head and neck cancer. Transl Oncol 2021;14:101017. [PMID: 33465746 DOI: 10.1016/j.tranon.2021.101017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Lamichhane A, Thakuri PS, Rafsanjani Nejad P, Tavana H. Modeling adaptive drug resistance of colorectal cancer and therapeutic interventions with tumor spheroids. Exp Biol Med (Maywood) 2021;:15353702211014185. [PMID: 34102903 DOI: 10.1177/15353702211014185] [Reference Citation Analysis]
12 Tang Y, Weng X, Liu C, Li X, Chen C. Hypoxia Enhances Activity and Malignant Behaviors of Colorectal Cancer Cells through the STAT3/MicroRNA-19a/PTEN/PI3K/AKT Axis. Anal Cell Pathol (Amst) 2021;2021:4132488. [PMID: 34796092 DOI: 10.1155/2021/4132488] [Reference Citation Analysis]
13 Singh M, Agarwal S, Agarwal V, Mall S, Pancham P, Mani S. Current theranostic approaches for metastatic cancers through hypoxia-induced exosomal packaged cargo. Life Sci 2021;286:120017. [PMID: 34619169 DOI: 10.1016/j.lfs.2021.120017] [Reference Citation Analysis]
14 Essa N, O'Connell F, Prina-Mello A, O'Sullivan J, Marcone S. Gold nanoparticles and obese adipose tissue microenvironment in cancer treatment. Cancer Lett 2022;525:1-8. [PMID: 34662546 DOI: 10.1016/j.canlet.2021.10.017] [Reference Citation Analysis]
15 Wang Z, Wang C, Fu J, Liu R, Zhou X, Jinhui L. Cinnamaldehyde Downregulation of Sept9 Inhibits Glioma Progression through Suppressing Hif-1α via the Pi3k/Akt Signaling Pathway. Disease Markers 2022;2022:1-13. [DOI: 10.1155/2022/6530934] [Reference Citation Analysis]
16 Walbrecq G, Margue C, Behrmann I, Kreis S. Distinct Cargos of Small Extracellular Vesicles Derived from Hypoxic Cells and Their Effect on Cancer Cells. Int J Mol Sci 2020;21:E5071. [PMID: 32709110 DOI: 10.3390/ijms21145071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Cho Y, Kim YK. Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance. Front Oncol 2020;10:764. [PMID: 32582535 DOI: 10.3389/fonc.2020.00764] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
18 Mo J, Mai Le NP, Priefer R. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers. Eur J Med Chem 2021;225:113770. [PMID: 34403979 DOI: 10.1016/j.ejmech.2021.113770] [Reference Citation Analysis]
19 Li K, Li J, Ye M, Jin X. The role of Siah2 in tumorigenesis and cancer therapy. Gene 2022;809:146028. [PMID: 34687788 DOI: 10.1016/j.gene.2021.146028] [Reference Citation Analysis]
20 Zhang M, Dong R, Yuan J, Da J, Zha Y, Long Y. Roxadustat (FG-4592) protects against ischaemia/reperfusion-induced acute kidney injury through inhibiting the mitochondrial damage pathway in mice. Clin Exp Pharmacol Physiol 2021. [PMID: 34653291 DOI: 10.1111/1440-1681.13601] [Reference Citation Analysis]
21 Kumar S, Behera A, Saha P, Kumar Srivastava A. The role of Krüppel-like factor 8 in cancer biology: Current research and its clinical relevance. Biochem Pharmacol 2021;183:114351. [PMID: 33253644 DOI: 10.1016/j.bcp.2020.114351] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Taleb M, Atabakhshi-Kashi M, Wang Y, Rezvani Alanagh H, Farhadi Sabet Z, Li F, Cheng K, Li C, Qi Y, Nie G, Ying Z. Bifunctional Therapeutic Peptide Assembled Nanoparticles Exerting Improved Activities of Tumor Vessel Normalization and Immune Checkpoint Inhibition. Adv Healthc Mater 2021;10:e2100051. [PMID: 34021735 DOI: 10.1002/adhm.202100051] [Reference Citation Analysis]
23 Yang Y, Li Y, Qi R, Zhang L. Constructe a novel 5 hypoxia genes signature for cervical cancer. Cancer Cell Int 2021;21:345. [PMID: 34217310 DOI: 10.1186/s12935-021-02050-3] [Reference Citation Analysis]
24 Shrestha B, Wang L, Brey EM, Uribe GR, Tang L. Smart Nanoparticles for Chemo-Based Combinational Therapy. Pharmaceutics 2021;13:853. [PMID: 34201333 DOI: 10.3390/pharmaceutics13060853] [Reference Citation Analysis]
25 Cole HD, Roque JA 3rd, Lifshits LM, Hodges R, Barrett PC, Havrylyuk D, Heidary D, Ramasamy E, Cameron CG, Glazer EC, McFarland SA. Fine-Feature Modifications to Strained Ruthenium Complexes Radically Alter Their Hypoxic Anticancer Activity. Photochem Photobiol 2021. [PMID: 33559191 DOI: 10.1111/php.13395] [Reference Citation Analysis]
26 Lavrentieva A. Gradient Hydrogels. Adv Biochem Eng Biotechnol 2021;178:227-51. [PMID: 33219386 DOI: 10.1007/10_2020_155] [Reference Citation Analysis]
27 Ma Q, Liu Y, Zhu H, Zhang L, Liao X. Nanozymes in Tumor Theranostics. Front Oncol 2021;11:666017. [PMID: 34737942 DOI: 10.3389/fonc.2021.666017] [Reference Citation Analysis]
28 Xiong L, Feng Y, Hu W, Tan J, Li S, Wang H. Expression of AOX1 Predicts Prognosis of Clear Cell Renal Cell Carcinoma. Front Genet 2021;12:683173. [PMID: 34290740 DOI: 10.3389/fgene.2021.683173] [Reference Citation Analysis]
29 Thomas RG, Surendran SP, Jeong YY. Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy. Front Mol Biosci 2020;7:610533. [PMID: 33392264 DOI: 10.3389/fmolb.2020.610533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
30 Nasry WHS, Martin CK. Intersecting Mechanisms of Hypoxia and Prostaglandin E2-Mediated Inflammation in the Comparative Biology of Oral Squamous Cell Carcinoma. Front Oncol 2021;11:539361. [PMID: 34094895 DOI: 10.3389/fonc.2021.539361] [Reference Citation Analysis]
31 Chen RL, Wang Z, Huang P, Sun CH, Yu WY, Zhang HH, Yu CH, He JQ. Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice. Int Immunopharmacol 2021;94:107357. [PMID: 33715980 DOI: 10.1016/j.intimp.2020.107357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Chu Y, Zhang W, Kanimozhi G, Brindha GR, Tian D. Ginsenoside Rg1 Induces Apoptotic Cell Death in Triple-Negative Breast Cancer Cell Lines and Prevents Carcinogen-Induced Breast Tumorigenesis in Sprague Dawley Rats. Evid Based Complement Alternat Med 2020;2020:8886955. [PMID: 33178325 DOI: 10.1155/2020/8886955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Zhong W, Zhong H, Zhang F, Huang C, Lin Y, Huang J. Characterization of Hypoxia-Related Molecular Subtypes in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy and Targeted Therapy via Multi-Omics Analysis. Front Mol Biosci 2021;8:684050. [PMID: 34250018 DOI: 10.3389/fmolb.2021.684050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Satija S, Sharma P, Kaur H, Dhanjal DS, Chopra RS, Khurana N, Vyas M, Sharma N, Tambuwala MM, Bakshi HA, Charbe NB, Zacconi FC, Chellappan DK, Dua K, Mehta M. Perfluorocarbons therapeutics in modern cancer nanotechnology for hypoxia-induced anti-tumor therapy. Curr Pharm Des 2021. [PMID: 34459378 DOI: 10.2174/1381612827666210830100907] [Reference Citation Analysis]
35 Chen L, He M, Zhang M, Sun Q, Zeng S, Zhao H, Yang H, Liu M, Ren S, Meng X, Xu H. The Role of non-coding RNAs in colorectal cancer, with a focus on its autophagy. Pharmacol Ther 2021;226:107868. [PMID: 33901505 DOI: 10.1016/j.pharmthera.2021.107868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
36 Gastelum G, Veena M, Lyons K, Lamb C, Jacobs N, Yamada A, Baibussinov A, Sarafyan M, Shamis R, Kraut J, Frost P. Can Targeting Hypoxia-Mediated Acidification of the Bone Marrow Microenvironment Kill Myeloma Tumor Cells? Front Oncol 2021;11:703878. [PMID: 34350119 DOI: 10.3389/fonc.2021.703878] [Reference Citation Analysis]
37 Geismann C, Arlt A. Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer. Cells 2020;9:E2353. [PMID: 33113836 DOI: 10.3390/cells9112353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Omran Z, Guise CP, Chen L, Rauch C, Abdalla AN, Abdullah O, Sindi IA, Fischer PM, Smaill JB, Patterson AV, Liu Y, Wang Q. Design, Synthesis and In-Vitro Biological Evaluation of Antofine and Tylophorine Prodrugs as Hypoxia-Targeted Anticancer Agents. Molecules 2021;26:3327. [PMID: 34206005 DOI: 10.3390/molecules26113327] [Reference Citation Analysis]
39 Gong PJ, Shao YC, Huang SR, Zeng YF, Yuan XN, Xu JJ, Yin WN, Wei L, Zhang JW. Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer. Front Oncol 2020;10:579868. [PMID: 33344235 DOI: 10.3389/fonc.2020.579868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Dai G, Yang Y, Liu S, Liu H. Hypoxic Breast Cancer Cell-Derived Exosomal SNHG1 Promotes Breast Cancer Growth and Angiogenesis via Regulating miR-216b-5p/JAK2 Axis. CMAR 2022;Volume 14:123-33. [DOI: 10.2147/cmar.s327621] [Reference Citation Analysis]
41 Bernauer C, Man YKS, Chisholm JC, Lepicard EY, Robinson SP, Shipley JM. Hypoxia and its therapeutic possibilities in paediatric cancers. Br J Cancer 2021;124:539-51. [PMID: 33106581 DOI: 10.1038/s41416-020-01107-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
42 Gavas S, Quazi S, Karpiński TM. Nanoparticles for Cancer Therapy: Current Progress and Challenges. Nanoscale Res Lett 2021;16:173. [PMID: 34866166 DOI: 10.1186/s11671-021-03628-6] [Reference Citation Analysis]
43 Omidkhah N, Ghodsi R. NO-HDAC dual inhibitors. Eur J Med Chem 2022;227:113934. [PMID: 34700268 DOI: 10.1016/j.ejmech.2021.113934] [Reference Citation Analysis]
44 Messeha SS, Zarmouh NO, Soliman KFA. Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer. Nutrients 2021;13:1718. [PMID: 34069461 DOI: 10.3390/nu13051718] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Khalaf K, Hana D, Chou JT, Singh C, Mackiewicz A, Kaczmarek M. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance. Front Immunol 2021;12:656364. [PMID: 34122412 DOI: 10.3389/fimmu.2021.656364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
46 Chen S, Chen M, Yang J, Zeng X, Zhou Y, Yang S, Yang R, Yuan Q, Zheng J. Design and Engineering of Hypoxia and Acidic pH Dual-Stimuli-Responsive Intelligent Fluorescent Nanoprobe for Precise Tumor Imaging. Small 2021;17:e2100243. [PMID: 34117822 DOI: 10.1002/smll.202100243] [Reference Citation Analysis]
47 Zhang C, Liao Y, Liu P, Du Q, Liang Y, Ooi S, Qin S, He S, Yao S, Wang W. FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism. Theranostics 2020;10:6561-80. [PMID: 32550890 DOI: 10.7150/thno.44868] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
48 Ziółkowska-Suchanek I, Podralska M, Żurawek M, Łaczmańska J, Iżykowska K, Dzikiewicz-Krawczyk A, Rozwadowska N. Hypoxia-Induced FAM13A Regulates the Proliferation and Metastasis of Non-Small Cell Lung Cancer Cells. Int J Mol Sci 2021;22:4302. [PMID: 33919074 DOI: 10.3390/ijms22094302] [Reference Citation Analysis]
49 Liapis E, Karlas A, Klemm U, Ntziachristos V. Chemotherapeutic effects on breast tumor hemodynamics revealed by eigenspectra multispectral optoacoustic tomography (eMSOT). Theranostics 2021;11:7813-28. [PMID: 34335966 DOI: 10.7150/thno.56173] [Reference Citation Analysis]
50 Bui TM, Yalom LK, Sumagin R. Tumor-associated neutrophils: orchestrating cancer pathobiology and therapeutic resistance. Expert Opin Ther Targets 2021;25:573-83. [PMID: 34236924 DOI: 10.1080/14728222.2021.1954162] [Reference Citation Analysis]
51 Devarajan N, Manjunathan R, Ganesan SK. Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients. Crit Rev Oncol Hematol 2021;162:103327. [PMID: 33862250 DOI: 10.1016/j.critrevonc.2021.103327] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Shahruzaman SH, Yusof FZ, Maniam S, Fakurazi S, Maniam S. The cytotoxic effect of Baeckea frustescens extracts in eliminating hypoxic breast cancer cells. BMC Complement Med Ther 2021;21:245. [PMID: 34598696 DOI: 10.1186/s12906-021-03417-9] [Reference Citation Analysis]
53 Tang K, Cheng Y, Li Q. Construction and Verification of a Hypoxia-Stemness-Based Gene Signature for Risk Stratification in Esophageal Cancer. Med Sci Monit 2021;27:e934359. [PMID: 34716287 DOI: 10.12659/MSM.934359] [Reference Citation Analysis]
54 Shi R, Tang Y, Miao H. Metabolism in tumor microenvironment: Implications for cancer immunotherapy. MedComm 2020;1:47-68. [DOI: 10.1002/mco2.6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
55 Park S, Oh JH, Park DJ, Zhang H, Noh M, Kim Y, Kim YS, Kim H, Kim YM, Ha SJ, Kwon YG. CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment via Cytotoxic T Cells. Front Immunol 2020;11:620166. [PMID: 33584714 DOI: 10.3389/fimmu.2020.620166] [Reference Citation Analysis]
56 Esteves M, Monteiro MP, Duarte JA. The effects of vascularization on tumor development: A systematic review and meta-analysis of pre-clinical studies. Crit Rev Oncol Hematol 2021;159:103245. [PMID: 33508446 DOI: 10.1016/j.critrevonc.2021.103245] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Zhao Y, Ting KK, Coleman P, Qi Y, Chen J, Vadas M, Gamble J. The Tumour Vasculature as a Target to Modulate Leucocyte Trafficking. Cancers (Basel) 2021;13:1724. [PMID: 33917287 DOI: 10.3390/cancers13071724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Jaroch K, Modrakowska P, Bojko B. Glioblastoma Metabolomics-In Vitro Studies. Metabolites 2021;11:315. [PMID: 34068300 DOI: 10.3390/metabo11050315] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Pucelik B, Sułek A, Barzowska A, Dąbrowski JM. Recent advances in strategies for overcoming hypoxia in photodynamic therapy of cancer. Cancer Lett 2020;492:116-35. [PMID: 32693200 DOI: 10.1016/j.canlet.2020.07.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
60 Yang QK, Wang XX, Wang Y, Ni N. Integrative Analysis Reveals the Landscape of Hypoxia-Inducible Factor (HIF) Family Genes in Pan-Cancer. J Oncol 2020;2020:8873104. [PMID: 33299416 DOI: 10.1155/2020/8873104] [Reference Citation Analysis]
61 Deng Z, Teng YJ, Zhou Q, Ouyang ZG, Hu YX, Long HP, Hu MJ, Mei S, Lin FX, Dai XJ, Zhang BY, Feng T, Tian XF. Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(11): 1725-1740 [PMID: 34853646 DOI: 10.4251/wjgo.v13.i11.1725] [Reference Citation Analysis]
62 Elsherbiny ME, Shaaban M, El-Tohamy R, Elkholi IE, Hammam OA, Magdy M, Allalunis-Turner J, Emara M. Expression of Myoglobin in Normal and Cancer Brain Tissues: Correlation With Hypoxia Markers. Front Oncol 2021;11:590771. [PMID: 33996536 DOI: 10.3389/fonc.2021.590771] [Reference Citation Analysis]
63 Guan XY, Guan XL, Jiao ZY. Improving therapeutic resistance: beginning with targeting the tumor microenvironment. J Chemother 2021;:1-25. [PMID: 34873999 DOI: 10.1080/1120009X.2021.2011661] [Reference Citation Analysis]
64 Lin W, Wu S, Chen X, Ye Y, Weng Y, Pan Y, Chen Z, Chen L, Qiu X, Qiu S. Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups. Front Oncol 2020;10:796. [PMID: 32500034 DOI: 10.3389/fonc.2020.00796] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
65 Wang D, Zhao C, Xu F, Zhang A, Jin M, Zhang K, Liu L, Hua Q, Zhao J, Liu J, Yang H, Huang G. Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2. Theranostics 2021;11:2860-75. [PMID: 33456577 DOI: 10.7150/thno.51797] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
66 Keša P, Pokorná E, Grajciarová M, Tonar Z, Vočková P, Trochet P, Kopeček M, Jakša R, Šefc L, Klener P. Quantitative In Vivo Monitoring of Hypoxia and Vascularization of Patient-Derived Murine Xenografts of Mantle Cell Lymphoma Using Photoacoustic and Ultrasound Imaging. Ultrasound Med Biol 2021;47:1099-107. [PMID: 33455807 DOI: 10.1016/j.ultrasmedbio.2020.12.010] [Reference Citation Analysis]
67 Emami Nejad A, Najafgholian S, Rostami A, Sistani A, Shojaeifar S, Esparvarinha M, Nedaeinia R, Haghjooy Javanmard S, Taherian M, Ahmadlou M, Salehi R, Sadeghi B, Manian M. The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment. Cancer Cell Int 2021;21:62. [PMID: 33472628 DOI: 10.1186/s12935-020-01719-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
68 Shen T, Xia W, Min S, Yang Z, Cheng L, Wang W, Zhan Q, Shao F, Zhang X, Wang Z, Zhang Y, Shen G, Zhang H, Wu LL, Yu GY, Kong QP, Wang X. A pair of long intergenic non-coding RNA LINC00887 variants act antagonistically to control Carbonic Anhydrase IX transcription upon hypoxia in tongue squamous carcinoma progression. BMC Biol 2021;19:192. [PMID: 34493285 DOI: 10.1186/s12915-021-01112-2] [Reference Citation Analysis]
69 Zeng Z, Lu Q, Liu Y, Zhao J, Zhang Q, Hu L, Shi Z, Tu Y, Xiao Z, Xu Q, Huang D. Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma. Front Oncol 2021;11:641522. [PMID: 34307125 DOI: 10.3389/fonc.2021.641522] [Reference Citation Analysis]
70 Woźniak M, Makuch S, Winograd K, Wiśniewski J, Ziółkowski P, Agrawal S. 6-Shogaol enhances the anticancer effect of 5-fluorouracil, oxaliplatin, and irinotecan via increase of apoptosis and autophagy in colon cancer cells in hypoxic/aglycemic conditions. BMC Complement Med Ther 2020;20:141. [PMID: 32393373 DOI: 10.1186/s12906-020-02913-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
71 Roy S, Kumaravel S, Sharma A, Duran CL, Bayless KJ, Chakraborty S. Hypoxic tumor microenvironment: Implications for cancer therapy. Exp Biol Med (Maywood) 2020;245:1073-86. [PMID: 32594767 DOI: 10.1177/1535370220934038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
72 Ortega MA, Fraile-Martinez O, García-Montero C, Callejón-Peláez E, Sáez MA, Álvarez-Mon MA, García-Honduvilla N, Monserrat J, Álvarez-Mon M, Bujan J, Canals ML. A General Overview on the Hyperbaric Oxygen Therapy: Applications, Mechanisms and Translational Opportunities. Medicina (Kaunas) 2021;57:864. [PMID: 34577787 DOI: 10.3390/medicina57090864] [Reference Citation Analysis]
73 Tian H, Zhu X, Lv Y, Jiao Y, Wang G. Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect. Cancer Manag Res 2020;12:5957-74. [PMID: 32765096 DOI: 10.2147/CMAR.S258196] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
74 Lan Y, Liang Y, Xiao X, Shi Y, Zhu M, Meng C, Yang S, Khan MT, Zhang YJ. Stoichioproteomics study of differentially expressed proteins and pathways in head and neck cancer. Braz J Biol 2021;83:e249424. [PMID: 34730606 DOI: 10.1590/1519-6984.249424] [Reference Citation Analysis]
75 Xu S, Tang L, Liu Z, Luo C, Cheng Q. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma. Front Immunol 2021;12:731048. [PMID: 34659218 DOI: 10.3389/fimmu.2021.731048] [Reference Citation Analysis]
76 Le Compte M, Komen N, Joye I, Peeters M, Prenen H, Smits E, Deben C, de Maat M. Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies. Crit Rev Oncol Hematol 2021;157:103190. [PMID: 33310278 DOI: 10.1016/j.critrevonc.2020.103190] [Reference Citation Analysis]
77 Wang W, Han Y, Jo HA, Lee J, Song YS. Non-coding RNAs shuttled via exosomes reshape the hypoxic tumor microenvironment. J Hematol Oncol 2020;13:67. [PMID: 32503591 DOI: 10.1186/s13045-020-00893-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
78 Fu Y, Bao Q, Liu Z, He G, Wen J, Liu Q, Xu Y, Jin Z, Zhang W. Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration. Front Cell Dev Biol 2021;9:633607. [PMID: 33816483 DOI: 10.3389/fcell.2021.633607] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
79 Hu Y, Wang K, Ye C. "Four-in-One" Nanozyme and Natural Enzyme Symbiotic System of Cu2-x Se-GOx for Cervical Cancer Therapy. Chemistry 2021. [PMID: 34773414 DOI: 10.1002/chem.202102885] [Reference Citation Analysis]
80 Kutova OM, Sencha LM, Pospelov AD, Dobrynina OE, Brilkina AA, Cherkasova EI, Balalaeva IV. Comparative Analysis of Cell-Cell Contact Abundance in Ovarian Carcinoma Cells Cultured in Two- and Three-Dimensional In Vitro Models. Biology (Basel) 2020;9:E446. [PMID: 33291824 DOI: 10.3390/biology9120446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Han Z, Tu X, Qiao L, Sun Y, Li Z, Sun X, Wu Z. Phototherapy and multimodal imaging of cancers based on perfluorocarbon nanomaterials. J Mater Chem B 2021;9:6751-69. [PMID: 34346475 DOI: 10.1039/d1tb00554e] [Reference Citation Analysis]
82 Saito-Takatsuji H, Yoshitomi Y, Ishigaki Y, Yamamoto S, Numata N, Sakai Y, Takeuchi M, Tomosugi N, Katsuda S, Yonekura H, Ikeda T. Protective Effects of Collagen Tripeptides in Human Aortic Endothelial Cells by Restoring ROS-Induced Transcriptional Repression. Nutrients 2021;13:2226. [PMID: 34209567 DOI: 10.3390/nu13072226] [Reference Citation Analysis]
83 Shou Y, Yang L, Yang Y, Zhu X, Li F, Xu J. Determination of hypoxia signature to predict prognosis and the tumor immune microenvironment in melanoma. Mol Omics 2021;17:307-16. [PMID: 33624645 DOI: 10.1039/d0mo00159g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
84 Shioya K, Matsumura T, Seki Y, Shimizu H, Nakamura T, Taniguchi S. Potentiated antitumor effects of APS001F/5-FC combined with anti-PD-1 antibody in a CT26 syngeneic mouse model. Biosci Biotechnol Biochem 2021;85:324-31. [PMID: 33604645 DOI: 10.1093/bbb/zbaa057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Madan E, Peixoto ML, Dimitrion P, Eubank TD, Yekelchyk M, Talukdar S, Fisher PB, Mi QS, Moreno E, Gogna R. Cell Competition Boosts Clonal Evolution and Hypoxic Selection in Cancer. Trends Cell Biol 2020;30:967-78. [PMID: 33160818 DOI: 10.1016/j.tcb.2020.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
86 Xue L, Liu J, Xie J, Luo J. Prognostic Value of SLC16A3(MCT4) in Lung Adenocarcinoma and Its Clinical Significance. Int J Gen Med 2021;14:8413-25. [PMID: 34819749 DOI: 10.2147/IJGM.S337615] [Reference Citation Analysis]
87 Sharma R, Kadife E, Myers M, Kannourakis G, Prithviraj P, Ahmed N. Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma. J Exp Clin Cancer Res 2021;40:186. [PMID: 34099013 DOI: 10.1186/s13046-021-01961-3] [Reference Citation Analysis]
88 Goyette MA, Elkholi IE, Apcher C, Kuasne H, Rothlin CV, Muller WJ, Richard DE, Park M, Gratton JP, Côté JF. Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels. Proc Natl Acad Sci U S A 2021;118:e2023868118. [PMID: 34266948 DOI: 10.1073/pnas.2023868118] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
89 Brum PO, Viola GD, Saibro-Girardi C, Tiefensee-Ribeiro C, Brum MO, Gasparotto J, Krolow R, Moreira JCF, Gelain DP. Hypoxia-Inducible Factor-1α (HIF-1α) Inhibition Impairs Retinoic Acid-Induced Differentiation in SH-SY5Y Neuroblastoma Cells, Leading to Reduced Neurite Length and Diminished Gene Expression Related to Cell Differentiation. Neurochem Res 2021. [PMID: 34557995 DOI: 10.1007/s11064-021-03454-3] [Reference Citation Analysis]
90 Li R, Chen Z, Dai Z, Yu Y. Nanotechnology assisted photo- and sonodynamic therapy for overcoming drug resistance. Cancer Biol Med 2021:j. [PMID: 33755377 DOI: 10.20892/j.issn.2095-3941.2020.0328] [Reference Citation Analysis]
91 Zeng Z, Zhao Y, Chen Q, Zhu S, Niu Y, Ye Z, Hu P, Chen D, Xu P, Chen J, Hu C, Hu Y, Xu F, Tang J, Wang F, Han S, Huang M, Wang C, Zhao G. Hypoxic exosomal HIF-1α-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis. Oncogene 2021. [PMID: 34294845 DOI: 10.1038/s41388-021-01960-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Ouyang X, Yao L, Liu G, Liu S, Gong L, Xiao Y. Loss of androgen receptor promotes HCC invasion and metastasis via activating circ-LNPEP/miR-532-3p/RAB9A signal under hypoxia. Biochem Biophys Res Commun 2021;557:26-32. [PMID: 33862456 DOI: 10.1016/j.bbrc.2021.02.120] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
93 Mansouri V, Beheshtizadeh N, Gharibshahian M, Sabouri L, Varzandeh M, Rezaei N. Recent advances in regenerative medicine strategies for cancer treatment. Biomed Pharmacother 2021;141:111875. [PMID: 34229250 DOI: 10.1016/j.biopha.2021.111875] [Reference Citation Analysis]
94 Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y, Wu S, Deng Y, Zhang J, Shao A. Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Front Mol Biosci 2020;7:193. [PMID: 32974385 DOI: 10.3389/fmolb.2020.00193] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
95 Cai C, Yang L, Zhou K. 8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma. BMC Gastroenterol 2021;21:463. [PMID: 34895169 DOI: 10.1186/s12876-021-02057-0] [Reference Citation Analysis]
96 Freeman P, Mielgo A. Cancer-Associated Fibroblast Mediated Inhibition of CD8+ Cytotoxic T Cell Accumulation in Tumours: Mechanisms and Therapeutic Opportunities. Cancers (Basel) 2020;12:E2687. [PMID: 32967079 DOI: 10.3390/cancers12092687] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
97 Sarnella A, D'Avino G, Hill BS, Alterio V, Winum JY, Supuran CT, De Simone G, Zannetti A. A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell Plasticity. Int J Mol Sci 2020;21:E8405. [PMID: 33182416 DOI: 10.3390/ijms21218405] [Reference Citation Analysis]
98 Ziółkowska-Suchanek I. Mimicking Tumor Hypoxia in Non-Small Cell Lung Cancer Employing Three-Dimensional In Vitro Models. Cells 2021;10:141. [PMID: 33445709 DOI: 10.3390/cells10010141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Zhou B, Gao S. Comprehensive Analysis of Clinical Significance, Immune Infiltration and Biological Role of m6A Regulators in Early-Stage Lung Adenocarcinoma. Front Immunol 2021;12:698236. [PMID: 34650549 DOI: 10.3389/fimmu.2021.698236] [Reference Citation Analysis]
100 Saitoh T, Oda T. DNA Damage Response in Multiple Myeloma: The Role of the Tumor Microenvironment. Cancers (Basel) 2021;13:504. [PMID: 33525741 DOI: 10.3390/cancers13030504] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
101 Liu Z, Liu L, Lu T, Wang L, Li Z, Jiao D, Han X. Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management.J Oncol. 2021;2021:6664386. [PMID: 33552157 DOI: 10.1155/2021/6664386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
102 Samoylenko A, Kögler M, Zhyvolozhnyi A, Makieieva O, Bart G, Andoh SS, Roussey M, Vainio SJ, Hiltunen J. Time-gated Raman spectroscopy and proteomics analyses of hypoxic and normoxic renal carcinoma extracellular vesicles. Sci Rep 2021;11:19594. [PMID: 34599227 DOI: 10.1038/s41598-021-99004-6] [Reference Citation Analysis]
103 Shi C, Zhang S, Guo C, Tie J. Yap-Hippo Signaling Activates Mitochondrial Protection and Sustains Breast Cancer Viability under Hypoxic Stress. J Oncol 2021;2021:5212721. [PMID: 34567116 DOI: 10.1155/2021/5212721] [Reference Citation Analysis]
104 He H, Chen T, Mo H, Chen S, Liu Q, Guo C. Hypoxia-inducible long noncoding RNA NPSR1-AS1 promotes the proliferation and glycolysis of hepatocellular carcinoma cells by regulating the MAPK/ERK pathway. Biochem Biophys Res Commun 2020;533:886-92. [PMID: 33008585 DOI: 10.1016/j.bbrc.2020.09.076] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
105 Li Y, Wei Y, Gu L. Effect of hypoxia on proliferation and glucocorticoid resistance of T-cell acute lymphoblastic leukaemia. Hematology 2021;26:775-84. [PMID: 34565306 DOI: 10.1080/16078454.2021.1980689] [Reference Citation Analysis]
106 Zhang Z, Wang R, Huang X, Zhu W, He Y, Liu W, Liu F, Feng F, Qu W. A Simple Aggregation-Induced Emission Nanoprobe with Deep Tumor Penetration for Hypoxia Detection and Imaging-Guided Surgery in Vivo. Anal Chem 2021;93:1627-35. [PMID: 33377760 DOI: 10.1021/acs.analchem.0c04101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
107 Gagliardi A, Giuliano E, Venkateswararao E, Fresta M, Bulotta S, Awasthi V, Cosco D. Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors. Front Pharmacol 2021;12:601626. [PMID: 33613290 DOI: 10.3389/fphar.2021.601626] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 17.0] [Reference Citation Analysis]
108 Li Q, Xiang M. Metabolic reprograming of MDSCs within tumor microenvironment and targeting for cancer immunotherapy. Acta Pharmacol Sin 2021. [PMID: 34561553 DOI: 10.1038/s41401-021-00776-4] [Reference Citation Analysis]
109 Estaras M, Gonzalez A. Modulation of cell physiology under hypoxia in pancreatic cancer. World J Gastroenterol 2021; 27(28): 4582-4602 [PMID: 34366624 DOI: 10.3748/wjg.v27.i28.4582] [Reference Citation Analysis]
110 Yan W, Lang T, Zhu R, Zhu X, Li Y, Wu T, Yin Q, Li Y. Anti-hypoxia nanosized drug delivery systems improving cancer therapy. Nano Today 2022;42:101376. [DOI: 10.1016/j.nantod.2022.101376] [Reference Citation Analysis]
111 Wu M, Ma M, Tan Z, Zheng H, Liu X. Neutrophil: A New Player in Metastatic Cancers. Front Immunol 2020;11:565165. [PMID: 33101283 DOI: 10.3389/fimmu.2020.565165] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
112 Park NJ, Jeong JY, Park JY, Kim HJ, Park CS, Lee J, Park HY, Jung JH, Kim WW, Chae YS, Lee SJ, Kim WH. Peritumoral edema in breast cancer at preoperative MRI: an interpretative study with histopathological review toward understanding tumor microenvironment. Sci Rep 2021;11:12992. [PMID: 34155253 DOI: 10.1038/s41598-021-92283-z] [Reference Citation Analysis]
113 Liverani C, De Vita A, Spadazzi C, Miserocchi G, Cocchi C, Bongiovanni A, De Lucia A, La Manna F, Fabbri F, Tebaldi M, Amadori D, Tasciotti E, Martinelli G, Mercatali L, Ibrahim T. Lineage-specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture. Mol Oncol 2021. [PMID: 34109737 DOI: 10.1002/1878-0261.13037] [Reference Citation Analysis]
114 Kalita-de Croft P, Sharma S, Sobrevia L, Salomon C. Extracellular vesicle interactions with the external and internal exposome in mediating carcinogenesis. Mol Aspects Med 2021;:101039. [PMID: 34629184 DOI: 10.1016/j.mam.2021.101039] [Reference Citation Analysis]
115 Zhang L, Wu H, Zhang Y, Xiao X, Chu F, Zhang L. Induction of lncRNA NORAD accounts for hypoxia-induced chemoresistance and vasculogenic mimicry in colorectal cancer by sponging the miR-495-3p/ hypoxia-inducible factor-1α (HIF-1α). Bioengineered 2022;13:950-62. [PMID: 34969360 DOI: 10.1080/21655979.2021.2015530] [Reference Citation Analysis]
116 Thomas SC, Madaan T, Kamble NS, Siddiqui NA, Pauletti GM, Kotagiri N. Engineered Bacteria Enhance Immunotherapy and Targeted Therapy through Stromal Remodeling of Tumors. Adv Healthc Mater 2021;:e2101487. [PMID: 34738725 DOI: 10.1002/adhm.202101487] [Reference Citation Analysis]
117 Li H, Zhou L, Zhou J, Li Q, Ji Q. Underlying mechanisms and drug intervention strategies for the tumour microenvironment. J Exp Clin Cancer Res 2021;40:97. [PMID: 33722297 DOI: 10.1186/s13046-021-01893-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Gao S, Chen T, Li L, Liu X, Liu Y, Zhao J, Lu Q, Zeng Z, Xu Q, Huang D, Tu K. Hypoxia-Inducible Ubiquitin Specific Peptidase 13 Contributes to Tumor Growth and Metastasis via Enhancing the Toll-Like Receptor 4/Myeloid Differentiation Primary Response Gene 88/Nuclear Factor-κB Pathway in Hepatocellular Carcinoma. Front Cell Dev Biol 2020;8:587389. [PMID: 33195243 DOI: 10.3389/fcell.2020.587389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
119 Chen J, Bao Y, Song Y, Zhang C, Qiu F, Sun Y, Xin L, Cao J, Jiang Y, Luo J, Zhang C, Wang G, Li Q, Liu Y, Tong W, Huang P. Hypoxia-alleviated nanoplatform to enhance chemosensitivity and sonodynamic effect in pancreatic cancer. Cancer Lett 2021;520:100-8. [PMID: 34245853 DOI: 10.1016/j.canlet.2021.07.008] [Reference Citation Analysis]
120 Kumar A, Deep G. Exosomes in hypoxia-induced remodeling of the tumor microenvironment. Cancer Lett 2020;488:1-8. [PMID: 32473240 DOI: 10.1016/j.canlet.2020.05.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
121 Zhu P, He F, Hou Y, Tu G, Li Q, Jin T, Zeng H, Qin Y, Wan X, Qiao Y, Qiu Y, Teng Y, Liu M. A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability. Oncogene 2021;40:1609-27. [PMID: 33469161 DOI: 10.1038/s41388-020-01638-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
122 Xu Z, Wei J, Qin F, Sun Y, Xiang W, Yuan L, Qin J, Deng K, Zheng T, Li S. Hypoxia-associated alternative splicing signature in lung adenocarcinoma. Epigenomics 2021;13:47-63. [PMID: 33336585 DOI: 10.2217/epi-2020-0399] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
123 Bughda R, Dimou P, D'Souza RR, Klampatsa A. Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma. Immunotargets Ther 2021;10:313-23. [PMID: 34386436 DOI: 10.2147/ITT.S291767] [Reference Citation Analysis]
124 Larson TS, Glish GL, Lockett MR. Spatially resolved quantification of drug metabolism and efficacy in 3D paper-based tumor mimics. Anal Chim Acta 2021;1186:339091. [PMID: 34756260 DOI: 10.1016/j.aca.2021.339091] [Reference Citation Analysis]
125 Izadi S, Moslehi A, Kheiry H, Karoon Kiani F, Ahmadi A, Masjedi A, Ghani S, Rafiee B, Karpisheh V, Hajizadeh F, Atyabi F, Assali A, Mirzazadeh Tekie FS, Namdar A, Ghalamfarsa G, Sojoodi M, Jadidi-Niaragh F. Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression. Pharm Res 2020;37:196. [PMID: 32944844 DOI: 10.1007/s11095-020-02892-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
126 Chen J, Huang J, Huang Q, Li J, Chen E, Xu W. RASA4 inhibits the HIFα signaling pathway to suppress proliferation of cervical cancer cells. Bioengineered 2021;12:10723-33. [PMID: 34752201 DOI: 10.1080/21655979.2021.2002499] [Reference Citation Analysis]
127 Morrow D, Minami J, Nathanson DA. Metabolic Vulnerabilities in Brain Cancer. Neurosurg Clin N Am 2021;32:159-69. [PMID: 33781499 DOI: 10.1016/j.nec.2020.12.006] [Reference Citation Analysis]
128 Liu L, Wang C, Li S, Qu Y, Xue P, Ma Z, Zhang X, Bai H, Wang J. ERO1L Is a Novel and Potential Biomarker in Lung Adenocarcinoma and Shapes the Immune-Suppressive Tumor Microenvironment. Front Immunol 2021;12:677169. [PMID: 34354701 DOI: 10.3389/fimmu.2021.677169] [Reference Citation Analysis]
129 Wang B, Zhao Q, Zhang Y, Liu Z, Zheng Z, Liu S, Meng L, Xin Y, Jiang X. Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy. J Exp Clin Cancer Res 2021;40:24. [PMID: 33422072 DOI: 10.1186/s13046-020-01820-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
130 Koga T, Suda K, Nishino M, Fujino T, Ohara S, Hamada A, Soh J, Tirunagaru V, Vellanki A, Doebele RC, Mitsudomi T. Activity and mechanism of acquired resistance to tarloxotinib in HER2 mutant lung cancer: an in vitro study. Transl Lung Cancer Res 2021;10:3659-70. [PMID: 34584864 DOI: 10.21037/tlcr-21-216] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Ardila DC, Aggarwal V, Singh M, Chattopadhyay A, Chaparala S, Sant S. Identifying Molecular Signatures of Distinct Modes of Collective Migration in Response to the Microenvironment Using Three-Dimensional Breast Cancer Models. Cancers (Basel) 2021;13:1429. [PMID: 33804802 DOI: 10.3390/cancers13061429] [Reference Citation Analysis]
132 Devarajan N, Jayaraman S, Mahendra J, Venkatratnam P, Rajagopal P, Palaniappan H, Ganesan SK. Berberine-A potent chemosensitizer and chemoprotector to conventional cancer therapies. Phytother Res 2021;35:3059-77. [PMID: 33559280 DOI: 10.1002/ptr.7032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
133 Huang R, Zhou PK. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduct Target Ther 2021;6:254. [PMID: 34238917 DOI: 10.1038/s41392-021-00648-7] [Reference Citation Analysis]
134 Popović KJ, Popović DJ, Miljković D, Popović JK, Lalošević D, Čapo I. Co-treatment with nitroglycerin and metformin exhibits physicochemically and pathohistologically detectable anticancer effects on fibrosarcoma in hamsters. Biomed Pharmacother 2020;130:110510. [PMID: 32707437 DOI: 10.1016/j.biopha.2020.110510] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
135 Li Z, Ning F, Wang C, Yu H, Ma Q, Sun Y. Normalization of the tumor microvasculature based on targeting and modulation of the tumor microenvironment. Nanoscale 2021;13:17254-71. [PMID: 34651623 DOI: 10.1039/d1nr03387e] [Reference Citation Analysis]
136 Kooshki L, Mahdavi P, Fakhri S, Akkol EK, Khan H. Targeting lactate metabolism and glycolytic pathways in the tumor microenvironment by natural products: A promising strategy in combating cancer. Biofactors 2021. [PMID: 34724274 DOI: 10.1002/biof.1799] [Reference Citation Analysis]
137 Farina AR, Cappabianca L, Sebastiano M, Zelli V, Guadagni S, Mackay AR. Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer. J Exp Clin Cancer Res. 2020;39:110. [PMID: 32536347 DOI: 10.1186/s13046-020-01616-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
138 Cao L, Zhu Y, Wang W, Wang G, Zhang S, Cheng H. Emerging Nano-Based Strategies Against Drug Resistance in Tumor Chemotherapy. Front Bioeng Biotechnol 2021;9:798882. [DOI: 10.3389/fbioe.2021.798882] [Reference Citation Analysis]
139 Abdullah NA, Md Hashim NF, Ammar A, Muhamad Zakuan N. An Insight into the Anti-Angiogenic and Anti-Metastatic Effects of Oridonin: Current Knowledge and Future Potential. Molecules 2021;26:775. [PMID: 33546106 DOI: 10.3390/molecules26040775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
140 Shi Y, Gong M, Deng Z, Liu H, Chang Y, Yang Z, Cai L. Tirapazamine suppress osteosarcoma cells in part through SLC7A11 mediated ferroptosis. Biochem Biophys Res Commun 2021;567:118-24. [PMID: 34147710 DOI: 10.1016/j.bbrc.2021.06.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
141 Klemba A, Bodnar L, Was H, Brodaczewska KK, Wcislo G, Szczylik CA, Kieda C. Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies. Int J Mol Sci 2020;21:E9492. [PMID: 33327450 DOI: 10.3390/ijms21249492] [Reference Citation Analysis]
142 Zhang J, Xue W, Xu K, Yi L, Guo Y, Xie T, Tong H, Zhou B, Wang S, Li Q, Liu H, Chen X, Fang J, Zhang W. Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI. Theranostics 2020;10:7245-59. [PMID: 32641990 DOI: 10.7150/thno.44427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
143 Li YC, Chen CH, Chang CL, Chiang JY, Chu CH, Chen HH, Yip HK. Melatonin and hyperbaric oxygen therapies suppress colorectal carcinogenesis through pleiotropic effects and multifaceted mechanisms. Int J Biol Sci 2021;17:3728-44. [PMID: 34671196 DOI: 10.7150/ijbs.62280] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Liu Z, Tang Q, Qi T, Othmane B, Yang Z, Chen J, Hu J, Zu X. A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer. Front Immunol 2021;12:725223. [PMID: 34484235 DOI: 10.3389/fimmu.2021.725223] [Reference Citation Analysis]
145 Michon S, Rodier F, Yu FTH. Targeted Anti-Cancer Provascular Therapy Using Ultrasound, Microbubbles, and Nitrite to Increase Radiotherapy Efficacy. Bioconjug Chem 2022. [PMID: 34990112 DOI: 10.1021/acs.bioconjchem.1c00510] [Reference Citation Analysis]
146 Kang JH, Lee SS, Kim JH, Byun JH, Kim HJ, Yoo C, Kim KP, Ryoo BY, Kim SC. Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer. Eur Radiol 2021;31:864-74. [PMID: 32813104 DOI: 10.1007/s00330-020-07134-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
147 Kim SW, Kim IK, Lee SH. Role of hyperoxic treatment in cancer. Exp Biol Med (Maywood) 2020;245:851-60. [PMID: 32326758 DOI: 10.1177/1535370220921547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
148 Li Y, Wu C, Zhai Y, Han R, Gu R, Ma Y, Gao P, Qian Z, Gu Y, Li S. Palliating the escalated post-PDT tumor hypoxia with a dual cascade oxygenation nanocomplex. Applied Materials Today 2022;26:101287. [DOI: 10.1016/j.apmt.2021.101287] [Reference Citation Analysis]
149 Bakhshinyan D, Savage N, Salim SK, Venugopal C, Singh SK. The Strange Case of Jekyll and Hyde: Parallels Between Neural Stem Cells and Glioblastoma-Initiating Cells. Front Oncol 2020;10:603738. [PMID: 33489908 DOI: 10.3389/fonc.2020.603738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Basak D, Uddin MN, Hancock J. The Role of Oxidative Stress and Its Counteractive Utility in Colorectal Cancer (CRC). Cancers (Basel) 2020;12:E3336. [PMID: 33187272 DOI: 10.3390/cancers12113336] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
151 Zhang H, Luo YB, Wu W, Zhang L, Wang Z, Dai Z, Feng S, Cao H, Cheng Q, Liu Z. The molecular feature of macrophages in tumor immune microenvironment of glioma patients. Comput Struct Biotechnol J 2021;19:4603-18. [PMID: 34471502 DOI: 10.1016/j.csbj.2021.08.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Paškevičiūtė M, Januškevičienė I, Sakalauskienė K, Raišutis R, Petrikaitė V. Evaluation of low-intensity pulsed ultrasound on doxorubicin delivery in 2D and 3D cancer cell cultures. Sci Rep 2020;10:16161. [PMID: 32999381 DOI: 10.1038/s41598-020-73204-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
153 Zhang C, Tang B, Hu J, Fang X, Bian H, Han J, Hou C, Sun F. Neutrophils correlate with hypoxia microenvironment and promote progression of non-small-cell lung cancer. Bioengineered 2021;12:8872-84. [PMID: 34637697 DOI: 10.1080/21655979.2021.1987820] [Reference Citation Analysis]
154 Ashrafizadeh M, Zarrabi A, Hashemipour M, Vosough M, Najafi M, Shahinozzaman M, Hushmandi K, Khan H, Mirzaei H. Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers. Pharmacological Research 2020;160:105199. [DOI: 10.1016/j.phrs.2020.105199] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
155 Luan S, Zeng X, Zhang C, Qiu J, Yang Y, Mao C, Xiao X, Zhou J, Zhang Y, Yuan Y. Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment. Front Cell Dev Biol 2021;9:664816. [PMID: 33816512 DOI: 10.3389/fcell.2021.664816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Xu Y, Nijhuis A, Keun HC. RNA-binding motif protein 39 (RBM39): An emerging cancer target. Br J Pharmacol 2020. [PMID: 33238031 DOI: 10.1111/bph.15331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
157 Temiz E, Koyuncu I, Durgun M, Caglayan M, Gonel A, Güler EM, Kocyigit A, Supuran CT. Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells. Int J Mol Sci 2021;22:6098. [PMID: 34198834 DOI: 10.3390/ijms22116098] [Reference Citation Analysis]
158 Kaweme NM, Zhou F. Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment. Front Immunol 2021;12:683381. [PMID: 34220833 DOI: 10.3389/fimmu.2021.683381] [Reference Citation Analysis]
159 Li Y, Gong T, Gao H, Chen Y, Li H, Zhao P, Jiang Y, Wang K, Wu Y, Zheng X, Bu W. ZIF-Based Nanoparticles Combine X-Ray-Induced Nitrosative Stress with Autophagy Management for Hypoxic Prostate Cancer Therapy. Angew Chem Int Ed Engl 2021;60:15472-81. [PMID: 33964189 DOI: 10.1002/anie.202103015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
160 Han S, Qi Y, Luo Y, Chen X, Liang H. Exosomal Long Non-Coding RNA: Interaction Between Cancer Cells and Non-Cancer Cells. Front Oncol 2020;10:617837. [PMID: 33520726 DOI: 10.3389/fonc.2020.617837] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 Klener P, Klanova M. Drug Resistance in Non-Hodgkin Lymphomas. Int J Mol Sci 2020;21:E2081. [PMID: 32197371 DOI: 10.3390/ijms21062081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
162 Hu C, Wang H, Lin L, Sun X, Wang D. Association between carbonic anhydrase 9 expression and poor prognosis in sinonasal squamous cell carcinoma. Ann Diagn Pathol 2020;49:151643. [PMID: 33126151 DOI: 10.1016/j.anndiagpath.2020.151643] [Reference Citation Analysis]
163 Wu Q, Yu X, Li J, Sun S, Tu Y. Metabolic regulation in the immune response to cancer. Cancer Commun (Lond) 2021;41:661-94. [PMID: 34145990 DOI: 10.1002/cac2.12182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
164 Cangelosi D, Morini M, Zanardi N, Sementa AR, Muselli M, Conte M, Garaventa A, Pfeffer U, Bosco MC, Varesio L, Eva A. Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming. Cancers (Basel) 2020;12:E2343. [PMID: 32825087 DOI: 10.3390/cancers12092343] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
165 Bromma K, Chithrani DB. Advances in Gold Nanoparticle-Based Combined Cancer Therapy. Nanomaterials (Basel) 2020;10:E1671. [PMID: 32858957 DOI: 10.3390/nano10091671] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
166 Benny S, Mishra R, Manojkumar MK, Aneesh TP. From Warburg effect to Reverse Warburg effect; the new horizons of anti-cancer therapy. Med Hypotheses 2020;144:110216. [PMID: 33254523 DOI: 10.1016/j.mehy.2020.110216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
167 Fukuda N, Takahashi S. Clinical Indications for Treatment with Multi-Kinase Inhibitors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer. Cancers (Basel) 2021;13:2279. [PMID: 34068664 DOI: 10.3390/cancers13092279] [Reference Citation Analysis]
168 Choudhry H. UCA1 Overexpression Promotes Hypoxic Breast Cancer Cell Proliferation and Inhibits Apoptosis via HIF-1α Activation. J Oncol 2021;2021:5512156. [PMID: 34054950 DOI: 10.1155/2021/5512156] [Reference Citation Analysis]
169 Yun CW, Lee JH, Go G, Jeon J, Yoon S, Lee SH. Prion Protein of Extracellular Vesicle Regulates the Progression of Colorectal Cancer. Cancers (Basel) 2021;13:2144. [PMID: 33946823 DOI: 10.3390/cancers13092144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
170 Esteves M, Monteiro MP, Duarte JA. The Effects of Physical Exercise on Tumor Vasculature: Systematic Review and Meta-analysis. Int J Sports Med 2021. [PMID: 34341974 DOI: 10.1055/a-1533-1876] [Reference Citation Analysis]
171 Lu S, Feng W, Dong C, Song X, Gao X, Guo J, Chen Y, Hu Z. Photosynthetic Oxygenation-Augmented Sonodynamic Nanotherapy of Hypoxic Tumors. Adv Healthc Mater 2021;:e2102135. [PMID: 34787379 DOI: 10.1002/adhm.202102135] [Reference Citation Analysis]
172 Mintz J, Vedenko A, Rosete O, Shah K, Goldstein G, Hare JM, Ramasamy R, Arora H. Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics. Vaccines (Basel) 2021;9:94. [PMID: 33513777 DOI: 10.3390/vaccines9020094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
173 Li Q, Liu M, Sun Y, Jin T, Zhu P, Wan X, Hou Y, Tu G. SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress. J Exp Clin Cancer Res 2021;40:168. [PMID: 33990217 DOI: 10.1186/s13046-021-01933-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 Dallavalle S, Dobričić V, Lazzarato L, Gazzano E, Machuqueiro M, Pajeva I, Tsakovska I, Zidar N, Fruttero R. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors. Drug Resist Updat 2020;50:100682. [PMID: 32087558 DOI: 10.1016/j.drup.2020.100682] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 18.5] [Reference Citation Analysis]
175 Hao X, Ren Y, Feng M, Wang Q, Wang Y. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more. Biomed Pharmacother 2021;141:111798. [PMID: 34120068 DOI: 10.1016/j.biopha.2021.111798] [Reference Citation Analysis]
176 Mortezaee K, Majidpoor J. The impact of hypoxia on immune state in cancer. Life Sci 2021;286:120057. [PMID: 34662552 DOI: 10.1016/j.lfs.2021.120057] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
177 Jha V, Kumari T, Manickam V, Assar Z, Olson KL, Min JK, Cho J. ERO1-PDI Redox Signaling in Health and Disease. Antioxid Redox Signal 2021. [PMID: 34074138 DOI: 10.1089/ars.2021.0018] [Reference Citation Analysis]
178 Zhang H, Qin C, Liu HW, Guo X, Gan H. An Effective Hypoxia-Related Long Non-Coding RNAs Assessment Model for Prognosis of Clear Cell Renal Carcinoma. Front Oncol 2021;11:616722. [PMID: 33692953 DOI: 10.3389/fonc.2021.616722] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
179 Aggarwal V, Miranda O, Johnston PA, Sant S. Three dimensional engineered models to study hypoxia biology in breast cancer. Cancer Lett 2020;490:124-42. [PMID: 32569616 DOI: 10.1016/j.canlet.2020.05.030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
180 Yang G, Shi R, Zhang Q. Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression. Int J Mol Sci 2020;21:E8162. [PMID: 33142830 DOI: 10.3390/ijms21218162] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
181 Li Q, Ren J, Chen Q, Liu W, Xu Z, Cao Y, Kang Y, Xue P. A HMCuS@MnO2 nanocomplex responsive to multiple tumor environmental clues for photoacoustic/fluorescence/magnetic resonance trimodal imaging-guided and enhanced photothermal/photodynamic therapy. Nanoscale 2020;12:12508-21. [PMID: 32497157 DOI: 10.1039/d0nr01547d] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
182 Prasad S, Chandra A, Cavo M, Parasido E, Fricke S, Lee Y, D’amone E, Gigli G, Albanese C, Rodriguez O, del Mercato LL. Optical and magnetic resonance imaging approaches for investigating the tumour microenvironment: state-of-the-art review and future trends. Nanotechnology 2021;32:062001. [DOI: 10.1088/1361-6528/abc208] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
183 Pakravan N, Abbasi A, Hassan ZM. Immunotherapy Using Oxygenated Water and Tumor-Derived Exosomes Potentiates Antitumor Immune Response and Attenuates Malignancy Tendency in Mice Model of Breast Cancer. Oxid Med Cell Longev 2021;2021:5529484. [PMID: 34194604 DOI: 10.1155/2021/5529484] [Reference Citation Analysis]
184 Olszewska A, Borkowska A, Granica M, Karolczak J, Zglinicki B, Kieda C, Was H. Escape From Cisplatin-Induced Senescence of Hypoxic Lung Cancer Cells Can Be Overcome by Hydroxychloroquine. Front Oncol 2022;11:738385. [DOI: 10.3389/fonc.2021.738385] [Reference Citation Analysis]
185 Du Y, Wei N, Ma R, Jiang SH, Song D. Long Noncoding RNA MIR210HG Promotes the Warburg Effect and Tumor Growth by Enhancing HIF-1α Translation in Triple-Negative Breast Cancer. Front Oncol 2020;10:580176. [PMID: 33392077 DOI: 10.3389/fonc.2020.580176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
186 Zhou C, Zhang H, Lu L. Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma. Front Genet 2021;12:744113. [PMID: 34650600 DOI: 10.3389/fgene.2021.744113] [Reference Citation Analysis]
187 Chen D, Huang H, Zang L, Gao W, Zhu H, Yu X. Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma. Front Immunol 2021;12:728062. [PMID: 34691034 DOI: 10.3389/fimmu.2021.728062] [Reference Citation Analysis]
188 Qi L, Chen J, Yang Y, Hu W. Hypoxia Correlates With Poor Survival and M2 Macrophage Infiltration in Colorectal Cancer. Front Oncol 2020;10:566430. [PMID: 33330037 DOI: 10.3389/fonc.2020.566430] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
189 Kawakubo H, Kamisuki S, Suzuki K, Izaguirre-Carbonell J, Saito S, Murata H, Tanabe A, Hongo A, Murakami H, Matsunaga S, Sakaguchi K, Sahara H, Sugawara F, Kuramochi K. SQAP, an acyl sulfoquinovosyl derivative, suppresses expression of histone deacetylase and induces cell death of cancer cells under hypoxic conditions. Biosci Biotechnol Biochem 2021;85:85-91. [PMID: 33577659 DOI: 10.1093/bbb/zbaa015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
190 Zhao C, Zhou Y, Ma H, Wang J, Guo H, Liu H. A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma. BMC Oral Health 2021;21:232. [PMID: 33941139 DOI: 10.1186/s12903-021-01587-z] [Reference Citation Analysis]
191 Shamis SAK, McMillan DC, Edwards J. The relationship between hypoxia-inducible factor 1α (HIF-1α) and patient survival in breast cancer: Systematic review and meta-analysis. Crit Rev Oncol Hematol 2021;159:103231. [PMID: 33482350 DOI: 10.1016/j.critrevonc.2021.103231] [Reference Citation Analysis]
192 Liu P, Huang H, Qi X, Bian C, Cheng M, Liu L, Xue L, Zhao X, Yi T, Quan Y. Hypoxia-Induced LncRNA-MIR210HG Promotes Cancer Progression By Inhibiting HIF-1α Degradation in Ovarian Cancer. Front Oncol 2021;11:701488. [PMID: 34900667 DOI: 10.3389/fonc.2021.701488] [Reference Citation Analysis]
193 Deng L, Meng T, Chen L, Wei W, Wang P. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther 2020;5:11. [PMID: 32296023 DOI: 10.1038/s41392-020-0107-0] [Cited by in Crossref: 54] [Cited by in F6Publishing: 65] [Article Influence: 27.0] [Reference Citation Analysis]
194 Liu Y, Yang Q, Zhang H, Han S, Liu N, Ren H, Guo H, Xu F. Construction of cancer-on-a-chip for drug screening. Drug Discov Today 2021;26:1875-90. [PMID: 33731317 DOI: 10.1016/j.drudis.2021.03.006] [Reference Citation Analysis]
195 Zhang Q, Qiao L, Liao J, Liu Q, Liu P, Liu L. A novel hypoxia gene signature indicates prognosis and immune microenvironments characters in patients with hepatocellular carcinoma. J Cell Mol Med 2021;25:3772-84. [PMID: 33616276 DOI: 10.1111/jcmm.16249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
196 Ruan W, Yang Y, Yu Q, Huang T, Wang Y, Hua L, Zeng Z, Pan R. FUT11 is a target gene of HIF1α that promotes the progression of hepatocellular carcinoma. Cell Biol Int 2021. [PMID: 34288238 DOI: 10.1002/cbin.11675] [Reference Citation Analysis]
197 Rho SB, Lee KW, Lee SH, Byun HJ, Kim BR, Lee CH. Novel Anti-Angiogenic and Anti-Tumour Activities of the N-Terminal Domain of NOEY2 via Binding to VEGFR-2 in Ovarian Cancer. Biomol Ther (Seoul) 2021;29:506-18. [PMID: 34462379 DOI: 10.4062/biomolther.2021.121] [Reference Citation Analysis]
198 Kim DS, Scherer PE. Obesity, Diabetes, and Increased Cancer Progression. Diabetes Metab J 2021;45:799-812. [PMID: 34847640 DOI: 10.4093/dmj.2021.0077] [Reference Citation Analysis]
199 P S R, Alvi SB, Begum N, Veeresh B, Rengan AK. Self-Assembled Fluorosome-Polydopamine Complex for Efficient Tumor Targeting and Commingled Photodynamic/Photothermal Therapy of Triple-Negative Breast Cancer. Biomacromolecules 2021. [PMID: 34383466 DOI: 10.1021/acs.biomac.1c00744] [Reference Citation Analysis]
200 Xu Y, Hu J, Cao C, Zhang M, Liu Y, Chen H, Wei S, Zhu Z, Yang Y, Yu L, Li J. Distinct Hypoxia-Related Gene Profiling Characterizes Clinicopathological Features and Immune Status of Mismatch Repair-Deficient Colon Cancer. J Oncol 2021;2021:2427427. [PMID: 34917146 DOI: 10.1155/2021/2427427] [Reference Citation Analysis]
201 Qin S, Jiang J, Lu Y, Nice EC, Huang C, Zhang J, He W. Emerging role of tumor cell plasticity in modifying therapeutic response. Signal Transduct Target Ther 2020;5:228. [PMID: 33028808 DOI: 10.1038/s41392-020-00313-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
202 Motofei IG. Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation. Semin Cancer Biol 2021:S1044-579X(21)00253-4. [PMID: 34695580 DOI: 10.1016/j.semcancer.2021.10.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
203 Babinčák M, Jendželovský R, Košuth J, Majerník M, Vargová J, Mikulášek K, Zdráhal Z, Fedoročko P. Death Receptor 5 (TNFRSF10B) Is Upregulated and TRAIL Resistance Is Reversed in Hypoxia and Normoxia in Colorectal Cancer Cell Lines after Treatment with Skyrin, the Active Metabolite of Hypericum spp. Cancers (Basel) 2021;13:1646. [PMID: 33916015 DOI: 10.3390/cancers13071646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 Balkrishnan R, Desai RP, Narayan A, Camacho FT, Flausino LE, Chammas R. Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: A Medicare SEER cohort analysis. Cancer Med 2021;10:5347-57. [PMID: 34184420 DOI: 10.1002/cam4.4088] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
205 Xia Y, Chen H, Li J, Hu H, Qian Q, He RX, Ding Z, Guo SS. Acoustic Droplet-Assisted Superhydrophilic-Superhydrophobic Microarray Platform for High-Throughput Screening of Patient-Derived Tumor Spheroids. ACS Appl Mater Interfaces 2021;13:23489-501. [PMID: 33983701 DOI: 10.1021/acsami.1c06655] [Reference Citation Analysis]
206 Cong S, Guo Q, Cheng Y, He Y, Zhao X, Kong C, Ning S, Zhang G. Immune Characterization of Ovarian Cancer Reveals New Cell Subtypes With Different Prognoses, Immune Risks, and Molecular Mechanisms. Front Cell Dev Biol 2020;8:614139. [PMID: 33409283 DOI: 10.3389/fcell.2020.614139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
207 Azwar S, Seow HF, Abdullah M, Faisal Jabar M, Mohtarrudin N. Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment. Biology (Basel) 2021;10:854. [PMID: 34571731 DOI: 10.3390/biology10090854] [Reference Citation Analysis]
208 Gnocchi D, Castellaneta F, Cesari G, Fiore G, Sabbà C, Mazzocca A. Treatment of liver cancer cells with ethyl acetate extract of Crithmum maritimum permits reducing sorafenib dose and toxicity maintaining its efficacy. J Pharm Pharmacol 2021:rgab070. [PMID: 34014301 DOI: 10.1093/jpp/rgab070] [Reference Citation Analysis]
209 Chan WJ, Tseng FG. Nanomedicine in boron neutron capture therapy for cancer treatment: opportunities, challenges and future perspectives. Nanomedicine (Lond) 2021;16:1631-4. [PMID: 34264135 DOI: 10.2217/nnm-2021-0082] [Reference Citation Analysis]
210 Sun H, Zhang D, Huang C, Guo Y, Yang Z, Yao N, Dong X, Cheng R, Zhao N, Meng J, Sun B, Hao J. Hypoxic microenvironment induced spatial transcriptome changes in pancreatic cancer. Cancer Biol Med 2021:j. [PMID: 34086429 DOI: 10.20892/j.issn.2095-3941.2021.0158] [Reference Citation Analysis]
211 Gu X, Meng H, Wang J, Wang R, Cao M, Liu S, Chen H, Xu Y. Hypoxia contributes to galectin-3 expression in renal carcinoma cells. Eur J Pharmacol 2021;890:173637. [PMID: 33065093 DOI: 10.1016/j.ejphar.2020.173637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
212 Liu Y, Hua F, Zhan Y, Yang Y, Xie J, Cheng Y, Li F. Carcinoma associated fibroblasts small extracellular vesicles with low miR-7641 promotes breast cancer stemness and glycolysis by HIF-1α. Cell Death Discov 2021;7:176. [PMID: 34238918 DOI: 10.1038/s41420-021-00524-x] [Reference Citation Analysis]
213 Marin JJG, Macias RIR, Monte MJ, Herraez E, Peleteiro-Vigil A, Blas BS, Sanchon-Sanchez P, Temprano AG, Espinosa-Escudero RA, Lozano E, Briz O, Romero MR. Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment. Cancers (Basel) 2020;12:E2605. [PMID: 32933095 DOI: 10.3390/cancers12092605] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
214 Ying Y, Xiang G, Chen M, Ye J, Wu Q, Dou H, Sheng S, Zhu S. Gelatine nanostructured lipid carrier encapsulated FGF15 inhibits autophagy and improves recovery in spinal cord injury. Cell Death Discov 2020;6:137. [PMID: 33298870 DOI: 10.1038/s41420-020-00367-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
215 Begum Y, Pandit A, Swarnakar S. Insights Into the Regulation of Gynecological Inflammation-Mediated Malignancy by Metalloproteinases. Front Cell Dev Biol 2021;9:780510. [PMID: 34912809 DOI: 10.3389/fcell.2021.780510] [Reference Citation Analysis]
216 Neganova M, Liu J, Aleksandrova Y, Klochkov S, Fan R. Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment. Cancers (Basel) 2021;13:6062. [PMID: 34885171 DOI: 10.3390/cancers13236062] [Reference Citation Analysis]
217 Zhang H, Dai Z, Wu W, Wang Z, Zhang N, Zhang L, Zeng WJ, Liu Z, Cheng Q. Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer. J Exp Clin Cancer Res 2021;40:184. [PMID: 34088360 DOI: 10.1186/s13046-021-01987-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
218 Wen J, Luo Y, Gao H, Zhang L, Wang X, Huang J, Shang T, Zhou D, Wang D, Wang Z, Li P, Wang Z. Mitochondria-targeted nanoplatforms for enhanced photodynamic therapy against hypoxia tumor. J Nanobiotechnology 2021;19:440. [PMID: 34930284 DOI: 10.1186/s12951-021-01196-6] [Reference Citation Analysis]
219 Das T, Anand U, Pandey SK, Ashby CR Jr, Assaraf YG, Chen ZS, Dey A. Therapeutic strategies to overcome taxane resistance in cancer. Drug Resist Updat 2021;55:100754. [PMID: 33691261 DOI: 10.1016/j.drup.2021.100754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
220 Zhang D, Zheng Y, Yang S, Li Y, Wang M, Yao J, Deng Y, Li N, Wei B, Wu Y, Zhu Y, Li H, Dai Z. Identification of a Novel Glycolysis-Related Gene Signature for Predicting Breast Cancer Survival. Front Oncol 2020;10:596087. [PMID: 33489894 DOI: 10.3389/fonc.2020.596087] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
221 Yasukochi Y, Shin S, Wakabayashi H, Maeda T. Transcriptomic Changes in Young Japanese Males After Exposure to Acute Hypobaric Hypoxia. Front Genet 2020;11:559074. [PMID: 33101380 DOI: 10.3389/fgene.2020.559074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
222 Jin Z, Zhao Q, Yuan S, Jiang W, Hu Y. Strategies of Alleviating Tumor Hypoxia and Enhancing Tumor Therapeutic Effect by Macromolecular Nanomaterials. Macromol Biosci 2021;21:e2100092. [PMID: 34008312 DOI: 10.1002/mabi.202100092] [Reference Citation Analysis]
223 Thomas E, Krause M. A new prognostic hypoxia biomarker consisting of imaging and gene-based data. EBioMedicine 2020;58:102901. [PMID: 32739865 DOI: 10.1016/j.ebiom.2020.102901] [Reference Citation Analysis]
224 Kim H, Pyo H, Kim H, Kang HW. Multi-Lens Arrays (MLA)-Assisted Photothermal Effects for Enhanced Fractional Cancer Treatment: Computational and Experimental Validations. Cancers (Basel) 2021;13:1146. [PMID: 33800182 DOI: 10.3390/cancers13051146] [Reference Citation Analysis]
225 Li H, Liu L, Huang T, Jin M, Zheng Z, Zhang H, Ye M, Liu K. Establishment of a novel ferroptosis-related lncRNA pair prognostic model in colon adenocarcinoma. Aging (Albany NY) 2021;13:23072-95. [PMID: 34610581 DOI: 10.18632/aging.203599] [Reference Citation Analysis]
226 Zhu F, Xu L, Li X, Li Z, Wang J, Chen H, Li X, Gao Y. Co-delivery of gefitinib and hematoporphyrin by aptamer-modified fluorinated dendrimer for hypoxia alleviation and enhanced synergistic chemo-photodynamic therapy of NSCLC. Eur J Pharm Sci 2021;167:106004. [PMID: 34520834 DOI: 10.1016/j.ejps.2021.106004] [Reference Citation Analysis]
227 Chen Y, Li Y, Huang L, Du Y, Gan F, Li Y, Yao Y. Antioxidative Stress: Inhibiting Reactive Oxygen Species Production as a Cause of Radioresistance and Chemoresistance. Oxid Med Cell Longev 2021;2021:6620306. [PMID: 33628367 DOI: 10.1155/2021/6620306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
228 Baczewska M, Bojczuk K, Kołakowski A, Dobroch J, Guzik P, Knapp P. Obesity and Energy Substrate Transporters in Ovarian Cancer-Review. Molecules 2021;26:1659. [PMID: 33809784 DOI: 10.3390/molecules26061659] [Reference Citation Analysis]
229 Li ZF, Meng DD, Liu YY, Bi FG, Tian K, Xu JZ, Sun JG, Gu CX, Li Y. Hypoxia inducible factor-3α promotes osteosarcoma progression by activating KDM3A-mediated demethylation of SOX9. Chem Biol Interact 2022;351:109759. [PMID: 34826399 DOI: 10.1016/j.cbi.2021.109759] [Reference Citation Analysis]
230 Wang Y, Gao W, Li Y, Chow ST, Xie W, Zhang X, Zhou J, Chan FL. Interplay between orphan nuclear receptors and androgen receptor-dependent or-independent growth signalings in prostate cancer. Mol Aspects Med 2021;78:100921. [PMID: 33121737 DOI: 10.1016/j.mam.2020.100921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
231 Singh R, Jain A, Palanichamy JK, Nag TC, Bakhshi S, Singh A. Ultrastructural changes in cristae of lymphoblasts in acute lymphoblastic leukemia parallel alterations in biogenesis markers. Appl Microsc 2021;51:20. [PMID: 34964922 DOI: 10.1186/s42649-021-00069-4] [Reference Citation Analysis]
232 Jiang F, Miao XL, Zhang XT, Yan F, Mao Y, Wu CY, Zhou GP. A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children. J Immunol Res 2021;2021:5523832. [PMID: 34337075 DOI: 10.1155/2021/5523832] [Reference Citation Analysis]
233 Kim JH, Verwilst P, Won M, Lee J, Sessler JL, Han J, Kim JS. A Small Molecule Strategy for Targeting Cancer Stem Cells in Hypoxic Microenvironments and Preventing Tumorigenesis. J Am Chem Soc 2021. [PMID: 34374290 DOI: 10.1021/jacs.1c03875] [Reference Citation Analysis]
234 Singh G, Storey KB. MicroRNA Cues from Nature: A Roadmap to Decipher and Combat Challenges in Human Health and Disease? Cells 2021;10:3374. [PMID: 34943882 DOI: 10.3390/cells10123374] [Reference Citation Analysis]
235 Zhang P, Zhang L, Wang J, Zhu L, Li Z, Chen H, Gao Y. An intelligent hypoxia-relieving chitosan-based nanoplatform for enhanced targeted chemo-sonodynamic combination therapy on lung cancer. Carbohydr Polym 2021;274:118655. [PMID: 34702474 DOI: 10.1016/j.carbpol.2021.118655] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Setargew YFI, Wyllie K, Grant RD, Chitty JL, Cox TR. Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours. Cancers (Basel) 2021;13:491. [PMID: 33513979 DOI: 10.3390/cancers13030491] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
237 Spoerri L, Gunasingh G, Haass NK. Fluorescence-Based Quantitative and Spatial Analysis of Tumour Spheroids: A Proposed Tool to Predict Patient-Specific Therapy Response. Front Digit Health 2021;3:668390. [PMID: 34713141 DOI: 10.3389/fdgth.2021.668390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
238 Rubin MA, Bristow RG, Thienger PD, Dive C, Imielinski M. Impact of Lineage Plasticity to and from a Neuroendocrine Phenotype on Progression and Response in Prostate and Lung Cancers. Mol Cell 2020;80:562-77. [PMID: 33217316 DOI: 10.1016/j.molcel.2020.10.033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
239 Sun X, Zhou Z, Zhang Y, Wang J, Zhao X, Jin L, Zhai T, Liu X, Zhang J, Mei W, Zhang B, Luo M, Yao X, Ye L. Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer. Cancer Cell Int 2021;21:251. [PMID: 33962639 DOI: 10.1186/s12935-021-01954-4] [Reference Citation Analysis]
240 Dadey RE, Workman CJ, Vignali DAA. Regulatory T Cells in the Tumor Microenvironment. Adv Exp Med Biol 2020;1273:105-34. [PMID: 33119878 DOI: 10.1007/978-3-030-49270-0_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
241 Jiang Y, Dong Y, Luo Y, Jiang S, Meng FL, Tan M, Li J, Zang Y. AMPK-mediated phosphorylation on 53BP1 promotes c-NHEJ. Cell Rep 2021;34:108713. [PMID: 33596428 DOI: 10.1016/j.celrep.2021.108713] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
242 Esteves M, Monteiro MP, Duarte JA. Role of Regular Physical Exercise in Tumor Vasculature: Favorable Modulator of Tumor Milieu. Int J Sports Med 2021;42:389-406. [PMID: 33307553 DOI: 10.1055/a-1308-3476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
243 Cai F, Li S, Huang H, Iqbal J, Wang C, Jiang X. Green synthesis of gold nanoparticles for immune response regulation: Mechanisms, applications, and perspectives. J Biomed Mater Res A 2021. [PMID: 34331516 DOI: 10.1002/jbm.a.37281] [Reference Citation Analysis]
244 Jiang Y, Jiang Z, Wang M, Ma L. Current Understandings and Clinical Translation of Nanomedicines for Breast Cancer Therapy. Adv Drug Deliv Rev 2021;:114034. [PMID: 34736986 DOI: 10.1016/j.addr.2021.114034] [Reference Citation Analysis]
245 Chen SY, Tsuneyama K, Yen MH, Lee JT, Chen JL, Huang SM. Hyperbaric oxygen suppressed tumor progression through the improvement of tumor hypoxia and induction of tumor apoptosis in A549-cell-transferred lung cancer. Sci Rep 2021;11:12033. [PMID: 34103583 DOI: 10.1038/s41598-021-91454-2] [Reference Citation Analysis]
246 Martín-Bernabé A, Tarragó-Celada J, Cunin V, Michelland S, Cortés R, Poignant J, Boyault C, Rachidi W, Bourgoin-Voillard S, Cascante M, Seve M. Quantitative Proteomic Approach Reveals Altered Metabolic Pathways in Response to the Inhibition of Lysine Deacetylases in A549 Cells under Normoxia and Hypoxia. Int J Mol Sci 2021;22:3378. [PMID: 33806075 DOI: 10.3390/ijms22073378] [Reference Citation Analysis]
247 Li F, Zhan L, Dong Q, Wang Q, Wang Y, Li X, Zhang Y, Zhang J. Tumor-Derived Exosome-Educated Hepatic Stellate Cells Regulate Lactate Metabolism of Hypoxic Colorectal Tumor Cells via the IL-6/STAT3 Pathway to Confer Drug Resistance. Onco Targets Ther 2020;13:7851-64. [PMID: 32821126 DOI: 10.2147/OTT.S253485] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
248 Pinto B, Henriques AC, Silva PMA, Bousbaa H. Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research. Pharmaceutics. 2020;12. [PMID: 33291351 DOI: 10.3390/pharmaceutics12121186] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
249 Barth DA, Prinz F, Teppan J, Jonas K, Klec C, Pichler M. Long-Noncoding RNA (lncRNA) in the Regulation of Hypoxia-Inducible Factor (HIF) in Cancer. Noncoding RNA 2020;6:E27. [PMID: 32640630 DOI: 10.3390/ncrna6030027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
250 Yang C, Zheng X, Cao S. Identification of a Hypoxia-Related lncRNA Biomarker Signature for Head and Neck Squamous Cell Carcinoma. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/6775496] [Reference Citation Analysis]
251 Yoon S, Hong J, Park B, Choi Y, Khan MS, Hwang J, Tanaka M, Choi J. Oxygen transport to mammalian cell and bacteria using nano-sized liposomes encapsulating oxygen molecules. J Biosci Bioeng 2021;132:657-65. [PMID: 34538590 DOI: 10.1016/j.jbiosc.2021.08.010] [Reference Citation Analysis]
252 Jiang F, Mao Y, Lu B, Zhou G, Wang J. A hypoxia risk signature for the tumor immune microenvironment evaluation and prognosis prediction in acute myeloid leukemia. Sci Rep 2021;11:14657. [PMID: 34282207 DOI: 10.1038/s41598-021-94128-1] [Reference Citation Analysis]
253 Zhang LL, Li Q, Zhong DS, Zhang WJ, Sun XJ, Zhu Y. MCM5 Aggravates the HDAC1-Mediated Malignant Progression of Lung Cancer. Front Cell Dev Biol 2021;9:669132. [PMID: 34409025 DOI: 10.3389/fcell.2021.669132] [Reference Citation Analysis]
254 Xu Y, Luo C, Wang J, Chen L, Chen J, Chen T, Zeng Q. Application of nanotechnology in the diagnosis and treatment of bladder cancer. J Nanobiotechnology 2021;19:393. [PMID: 34838048 DOI: 10.1186/s12951-021-01104-y] [Reference Citation Analysis]
255 Bao X, Zhang J, Huang G, Yan J, Xu C, Dou Z, Sun C, Zhang H. The crosstalk between HIFs and mitochondrial dysfunctions in cancer development. Cell Death Dis 2021;12:215. [PMID: 33637686 DOI: 10.1038/s41419-021-03505-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
256 Cha JE, Bae WY, Choi JS, Lee SH, Jeong JW. Angiogenic activities are increased via upregulation of HIF-1α expression in gefitinib-resistant non-small cell lung carcinoma cells. Oncol Lett 2021;22:671. [PMID: 34345296 DOI: 10.3892/ol.2021.12932] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
257 Babaei G, Aziz SG, Jaghi NZZ. EMT, cancer stem cells and autophagy; The three main axes of metastasis. Biomed Pharmacother 2021;133:110909. [PMID: 33227701 DOI: 10.1016/j.biopha.2020.110909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
258 Huang Q, Sun Y, Wang W, Lin LC, Huang Y, Yang J, Wu X, Kong L, Lu JJ. Biological Guided Carbon-Ion Microporous Radiation to Tumor Hypoxia Area Triggers Robust Abscopal Effects as Open Field Radiation. Front Oncol 2020;10:597702. [PMID: 33330089 DOI: 10.3389/fonc.2020.597702] [Reference Citation Analysis]
259 Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, Wu Y, Daldrup-Link HE. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacol Res 2021;171:105780. [PMID: 34302977 DOI: 10.1016/j.phrs.2021.105780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
260 Yuan CS, Deng ZW, Qin D, Mu YZ, Chen XG, Liu Y. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand? Acta Biomater 2021;125:1-28. [PMID: 33639310 DOI: 10.1016/j.actbio.2021.02.030] [Reference Citation Analysis]
261 Rizzo M. Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAs. Biochim Biophys Acta Rev Cancer 2021;1875:188481. [PMID: 33217485 DOI: 10.1016/j.bbcan.2020.188481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
262 Corrado C, Fontana S. Hypoxia and HIF Signaling: One Axis with Divergent Effects. Int J Mol Sci 2020;21:E5611. [PMID: 32764403 DOI: 10.3390/ijms21165611] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
263 Meng S, Alanazi R, Ji D, Bandura J, Luo ZW, Fleig A, Feng ZP, Sun HS. Role of TRPM7 kinase in cancer. Cell Calcium 2021;96:102400. [PMID: 33784560 DOI: 10.1016/j.ceca.2021.102400] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
264 Liu Y, Liu L, Mou ZX. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines. Biochem Genet 2021. [PMID: 34143331 DOI: 10.1007/s10528-021-10094-3] [Reference Citation Analysis]
265 Anduran E, Dubois LJ, Lambin P, Winum JY. Hypoxia-activated prodrug derivatives of anti-cancer drugs: a patent review 2006 - 2021. Expert Opin Ther Pat 2021;:1-12. [PMID: 34241566 DOI: 10.1080/13543776.2021.1954617] [Reference Citation Analysis]
266 Quagliano A, Gopalakrishnapillai A, Barwe SP. Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in Cancer. Front Oncol 2020;10:992. [PMID: 32670880 DOI: 10.3389/fonc.2020.00992] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
267 Yin WM, Li YW, Gu YQ, Luo M. Nanoengineered targeting strategy for cancer immunotherapy. Acta Pharmacol Sin 2020;41:902-10. [PMID: 32398683 DOI: 10.1038/s41401-020-0417-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
268 Li W, Han S, Hu P, Chen D, Zeng Z, Hu Y, Xu F, Tang J, Wang F, Zhao Y, Huang M, Zhao G. LncRNA ZNFTR functions as an inhibitor in pancreatic cancer by modulating ATF3/ZNF24/VEGFA pathway. Cell Death Dis 2021;12:830. [PMID: 34480024 DOI: 10.1038/s41419-021-04119-3] [Reference Citation Analysis]
269 Abbasi A, Pakravan N, Hassan ZM. Hyaluronic Acid Improves Hydrogen Peroxide Modulatory Effects on Calcium Channel and Sodium-Potassium Pump in 4T1 Breast Cancer Cell Line. Oxid Med Cell Longev 2020;2020:8681349. [PMID: 33456676 DOI: 10.1155/2020/8681349] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
270 Cao R, Ma B, Wang G, Xiong Y, Tian Y, Yuan L. Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer. Mol Ther Oncolytics 2021;22:277-93. [PMID: 34553019 DOI: 10.1016/j.omto.2021.06.011] [Reference Citation Analysis]
271 Li C, Li J, Li Y, Li L, Luo Y, Li J, Zhang Y, Wang Y, Liu X, Zhou X, Gong H, Jin X, Liu Y. Isorhamnetin Promotes MKN-45 Gastric Cancer Cell Apoptosis by Inhibiting PI3K-Mediated Adaptive Autophagy in a Hypoxic Environment. J Agric Food Chem 2021;69:8130-43. [PMID: 34269571 DOI: 10.1021/acs.jafc.1c02620] [Reference Citation Analysis]
272 Shou Y, Yang L, Yang Y, Zhu X, Li F, Xu J. Identification of Signatures of Prognosis Prediction for Melanoma Using a Hypoxia Score. Front Genet 2020;11:570530. [PMID: 33133157 DOI: 10.3389/fgene.2020.570530] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
273 Anichini G, Carrassa L, Stecca B, Marra F, Raggi C. The Role of the Hedgehog Pathway in Cholangiocarcinoma. Cancers (Basel) 2021;13:4774. [PMID: 34638259 DOI: 10.3390/cancers13194774] [Reference Citation Analysis]
274 Li TR, Chatterjee M, Lala M, Abraham AK, Freshwater T, Jain L, Sinha V, de Alwis DP, Mayawala K. Pivotal Dose of Pembrolizumab: A Dose-Finding Strategy for Immuno-Oncology. Clin Pharmacol Ther 2021;110:200-9. [PMID: 33462831 DOI: 10.1002/cpt.2170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
275 Liu Z, Wu M, Lan M, Zhang W. Boosting cancer therapy efficiency via photoinduced radical production. Chem Sci 2021;12:9500-5. [PMID: 34349925 DOI: 10.1039/d1sc01220g] [Reference Citation Analysis]
276 Cheng YC, Su LY, Chen LH, Lu TP, Chuang EY, Tsai MH, Chuang LL, Lai LC. Regulatory Mechanisms and Functional Roles of Hypoxia-Induced Long Non-Coding RNA MTORT1 in Breast Cancer Cells. Front Oncol 2021;11:663114. [PMID: 34141617 DOI: 10.3389/fonc.2021.663114] [Reference Citation Analysis]
277 Li Q, Ni Y, Zhang L, Jiang R, Xu J, Yang H, Hu Y, Qiu J, Pu L, Tang J, Wang X. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation. Signal Transduct Target Ther 2021;6:76. [PMID: 33619246 DOI: 10.1038/s41392-020-00453-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
278 Mckertish CM, Kayser V. Advances and Limitations of Antibody Drug Conjugates for Cancer. Biomedicines 2021;9:872. [PMID: 34440076 DOI: 10.3390/biomedicines9080872] [Reference Citation Analysis]
279 Zhang Y, Li T, Hu Y, Chen J, He Y, Gao X, Zhang Y. Co-delivery of doxorubicin and curcumin via cRGD-peptide modified PEG-PLA self-assembly nanomicelles for lung cancer therapy. Chinese Chemical Letters 2021. [DOI: 10.1016/j.cclet.2021.11.076] [Reference Citation Analysis]
280 Jiang J, Xu H, Wang Y, Lu H. Identification and Validation of Autophagy-Related Gene Nomograms to Predict the Prognostic Value of Patients with Cervical Cancer. J Oncol 2021;2021:5583400. [PMID: 34257653 DOI: 10.1155/2021/5583400] [Reference Citation Analysis]